SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide, displaying greater stability in human plasma and liver S9 enzymes assay. It improves bioavailability and half-life when administered orally and is a potent SARS-CoV-2 inhibitor with an IC50 of
Molecular Weight:
327.12
CAS Number:
[56961-10-5]
Formula:
C13H8Cl2N2O4
Target:
SARS-CoV
T60919
* VAT and and shipping costs not included. Errors and price changes excepted